Two Sigma Securities, LLC Verastem, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.39 - $0.71 $10,124 - $18,432	25,961 New	25,961 $10,000
Q2 2022 Aug 15, 2022	BUY	$1.02 - $1.83 $16,255 - $29,164	15,937 New	15,937 $18,000
Q4 2020 Feb 16, 2021	SELL	$1.15 - $2.4 $26,325 - $54,940	-22,892 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $25,410 - $38,458	22,892 New	22,892 $28,000
Q1 2020 May 15, 2020	SELL	$1.26 - $3.38 $27,793 - $74,556	-22,058 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.86 - $1.44 $18,969 - $31,763	22,058 New	22,058 $30,000
Q4 2017 Feb 14, 2018	SELL	$2.99 - $4.85 $41,058 - $66,600	-13,732 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.01 - $5.41 $41,333 - $74,290	13,732	13,732 $65,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.18B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.